Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its interim results for the six months ended 30 June 2024 (the "Reporting Period"). In the first half of 2024, the Group continued to deeply implement its overall business philosophy of 'in-depth services and lean operations'.
More info..

The Hong Kong Investor Relations Association ("HKIRA") today announced the winners of the 10th Investor Relations Awards 2024 (the "IR Awards" or the "Awards").
More info..

Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its first annual results for the year ended December 31, 2022 (the "Reporting Period") since its listing.
More info..

Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its first interim results for the six months ended 30 June 2022 (the "Reporting Period") since its listing.
More info..

A medical operation services provider in China - Yunkang Group Limited ("Yunkang Group" or the "Company", stock code: 2325.HK, together with its subsidiaries, collectively as the "Group"), has successfully listed and commenced dealings on the Main Board of the Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange") today, under the stock code of 2325 and in board lot of 500 shares each.
More info..

A medical operation services provider in China - Yunkang Group Limited ("Yunkang Group" or the "Company", stock code: 2325.HK, together with its subsidiaries, collectively as the "Group"), today announced the proposed listing of its Shares on the Main Board of Hong Kong Exchanges and Clearing Limited ("Hong Kong Stock Exchange").
More info..